Brixadi (Injectable Buprenorphine)
IRB 2210402
Approved small_molecule active
Quick answer
Brixadi (Injectable Buprenorphine) for Opioid Use Disorder is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opioid Use Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- active